How LifeArc aims to support charities, researchers and funders exploring new uses for existing medicines
The status of scientific understanding of MND and the ambition behind creating the joint fund with the MND Association
Catriona Crombie outlines the case studies from our seminar on drug repurposing
Ciaran Fulton, Head of Diagnostics, reflects on the rapid evolution of diagnostics during the pandemic.
Anji Miller, Senior Business Manager and advocate for diversity, discusses representation in science for International Women's Day 2021.
At a time when the world is looking to science for the answers, LifeArc marks the UN’s…
Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back.
An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in patients thanks to the perseverance of the charity team at LifeArc.